SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 216,497.52 |
Enterprise Value ($M) | 250,763.52 |
Book Value ($M) | 95,917.00 |
Book Value / Share | 16.99 |
Price / Book | 2.26 |
NCAV ($M) | -44,303.00 |
NCAV / Share | -7.85 |
Price / NCAV | -4.89 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.21 |
Return on Assets (ROA) | 0.16 |
Return on Equity (ROE) | 0.38 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.11 |
Current Ratio | 1.37 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 50,078.00 |
Assets | 195,617.00 |
Liabilities | 94,381.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 100,330.00 |
Operating Income | 38,870.00 |
Net Income | 31,372.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 29,267.00 |
Cash from Investing | -15,783.00 |
Cash from Financing | -14,834.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 8.94 | 7.82 | |
13G/A | State Street Corp | 5.08 | -0.29 | |
13G/A | BlackRock Inc. | 7.90 | 8.02 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,230,092 | 22,736,353 | 9.81 | |
2,815,783 | 20,256,137 | 13.90 | |
3,916,399 | 46,166,333 | 8.48 | |
2,639,804 | 24,371,098 | 10.83 | |
(click for more detail) |
Similar Companies | |
---|---|
NUVB – Nuvation Bio Inc – Class A | OGN – Organon & Co. |
PBH – Prestige Consumer Healthcare Inc | PRGO – Perrigo Company plc |
QGEN – Qiagen NV |
Financial data and stock pages provided by
Fintel.io